P2RX7 and retina neoplasm: The first cellular model was derived from retinal tumors of a transgenic mouse line and showed biochemical and cellular properties of photoreceptors, while the P2X7 receptor has been proposed as a potential therapeutic target in Central Nervous System (CNS) diseases [37,38].